Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Beclomethasone Dipropionate for Prevention of Acute GVHD
NCT00489203Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Apr 2007
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of beclomethasone dipropionate in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Fred Hutchinson Cancer Center. Started Apr 2007; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT00489203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489203.